Study Links Retinal Changes to Early Detection of Atrial Fibrillation Risk
Atrial fibrillation (AFib) affects approximately 52.55 million individuals globally, leading to serious health risks such as stroke, heart failure, and dementia. Many individuals with AFib are unaware of their condition, with studies indicating that around 62% of those diagnosed did not recognize their symptoms prior to diagnosis. A new study published in the journal PLOS Digital Health presents findings that suggest specific changes in the retina may allow for the detection of AFib risk as early as four years before a formal diagnosis is made.
In this study, researchers conducted a comprehensive analysis of optical coherence tomography (OCT) scans and color retinal photographs from more than 90,000 participants, sourced from two large cohort studies: AlzEye and the U.K. Biobank. Dr. Josef Huemer, a consultant ophthalmologist at Moorfields Eye Hospital and the study's lead author, emphasized the unique capability of the retina to provide a non-invasive view of blood vessels and nerve fiber tissue through commonly available eye tests.
The study found that individuals with AFib exhibited a consistent thinning of the macular ganglion cells and inner plexiform layer (mGCIPL) of the retina. This layer is critical as it relays visual information to the brain. Dr. Huemer explained that the thinning observed is indicative of past degeneration, likely due to mini strokes in the brain, a common occurrence in AFib patients. Notably, this thinning was identified in both hospital-based patients and healthy volunteers, reinforcing the reliability of the findings.
Additionally, the research uncovered thinning in the inner nuclear layer of the retina, which is hypothesized to be linked to cardiovascular disease, as this area is particularly vulnerable to micro strokes. Among participants who did not initially have AFib, those who later developed the condition showed thinner mGCIPL layers on average four years prior to their diagnosis.
Dr. Huemer highlighted the significance of these findings, noting the challenges in diagnosing AFib and the potential for OCT scans to quantify retinal changes easily. The next phase of research aims to explore whether these findings can refine risk calculations and improve early identification of patients who may benefit from long-term monitoring via electrocardiograms.
The study's implications extend beyond AFib detection, as it suggests a broader connection between cardiovascular health and retinal changes. Dr. Benjamin Bert, an ophthalmologist not involved in the study, noted the potential for 'silent ischemia'—episodes of inadequate blood flow—to cause damage leading to thinning of retinal layers. Dr. Cheng-Han Chen, an interventional cardiologist, echoed the importance of identifying individuals at risk for AFib through routine eye imaging, which could enhance cardiovascular monitoring.
While these findings are promising, further research is necessary to fully understand the biological changes in the eye associated with AFib and to evaluate the effectiveness of eye imaging as a practical screening tool across diverse populations. The study represents an early step toward elucidating the potential connection between ocular health and cardiovascular conditions, warranting continued investigation in this area.




